|73.19||+0.13 / +0.18%|
Data as of 4:00pm ET
|73.05||-0.14 / -0.19%|
The 14 analysts offering 12-month price forecasts for Edwards Lifesciences Corp have a median target of 72.00, with a high estimate of 80.00 and a low estimate of 60.00. The median estimate represents a -1.63% decrease from the last price of 73.19.
The current consensus among 21 polled investment analysts is to Hold stock in Edwards Lifesciences Corp. This rating has held steady since February, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.